The medicated liquid soap market size has grown rapidly in recent years. It will grow from $1.59 billion in 2025 to $1.78 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing prevalence of skin infections, rising awareness of personal hygiene, expansion of healthcare-associated infection control, growth in dermatology treatments, availability of medicated cleansing formulations.
The medicated liquid soap market size is expected to see rapid growth in the next few years. It will grow to $2.73 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing demand for preventive skin care, rising adoption of prescription-grade hygiene products, expansion of e-commerce pharmaceutical sales, growing focus on sensitive skin formulations, increasing regulatory oversight on topical products. Major trends in the forecast period include growing demand for antimicrobial personal care products, rising preference for dermatologically tested formulations, expansion of natural and herbal medicated soaps, enhanced focus on skin-specific therapeutic solutions, increasing use in clinical hygiene protocols.
The increasing prevalence of skin-related issues is expected to drive the growth of the medicated liquid soap market. Skin conditions such as acne, eczema, psoriasis, rashes, and infections are becoming more common due to rising exposure to environmental pollutants, which weaken the skin's barrier and trigger irritation. Medicated liquid soap helps address these concerns by eliminating harmful microbes that cause infections, acne, and irritation. It also contains active ingredients that cleanse thoroughly while calming inflammation and promoting skin repair. For example, in February 2025, Cancer Australia reported 18,257 new cases of skin melanoma in 2023, making up 11% of all new cancer cases, with 1,314 deaths from the disease. As skin issues become more widespread, the demand for products such as medicated liquid soap is increasing, fueling market growth.
Companies in the medicated liquid soap market are innovating with advanced products, such as antibacterial liquid soap, to enhance germ protection and offer a more effective and gentle cleansing experience. Antibacterial liquid soap is formulated to eliminate or inhibit bacterial growth on the skin, reducing the risk of infection and improving hygiene. For example, in April 2023, Dettol, a leading UK-based hygiene brand, introduced a reformulated version of its original liquid hand wash. The new formula provides 99.99% germ protection and a moisture seal benefit, while being dermatologically tested for gentle care. This enhanced version leaves hands feeling soft and nourished, offering both cleanliness and skin protection. Such innovations are helping to meet the growing demand for more effective, skin-friendly hygiene products.
In December 2023, Wipro Consumer Care and Lighting, an India-based personal care company, acquired three soap brands from VVF Limited. This acquisition strengthens Wipro’s position in the hygiene and wellness category by expanding its personal wash portfolio, which includes medicated liquid soaps. VVF Limited, a manufacturer of medicated liquid soap, has been a key player in this market. By acquiring these brands, Wipro aims to increase its market share in the fast-growing personal care segment, responding to the rising consumer demand for effective hygiene products.
Major companies operating in the medicated liquid soap market are Johnson & Johnson Services Inc., Unilever PLC, Reckitt Benckiser Group plc, Ecolab Inc., Kao Corporation, ITC Limited, Lion Corporation, Godrej Consumer Products Limited, GOJO Industries Inc., Vi-Jon LLC, Kutol Products Company Inc., Betco Corporation, Wipro Consumer Care and Lighting, Swisskem Healthcare, Trio Lifescience Pvt. Ltd., Kavit Soap Industries, Galderma, Glenmark Pharmaceuticals, Cipla, Beiersdorf AG, Sanofi, Perrigo Company plc.
North America was the largest region in the medicated liquid soap market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medicated liquid soap market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medicated liquid soap market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the medicated liquid soap market by increasing costs of imported active pharmaceutical ingredients, specialty surfactants, packaging materials, and formulation chemicals. Pharmaceutical and personal care manufacturers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressure on export-oriented soap production. These tariffs are raising manufacturing expenses and retail prices. However, they are also encouraging local ingredient sourcing, domestic formulation development, and investment in regional production facilities.
The medicated liquid soap market research report is one of a series of new reports that provides medicated liquid soap market statistics, including medicated liquid soap industry global market size, regional shares, competitors with a medicated liquid soap market share, detailed medicated liquid soap market segments, market trends and opportunities, and any further data you may need to thrive in the medicated liquid soap industry. This medicated liquid soap market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Medicated liquid soap is a specialized type of liquid soap that contains active pharmaceutical ingredients designed to treat or prevent specific skin conditions. Unlike regular cleansing soaps, medicated liquid soaps provide therapeutic benefits, often possessing antibacterial, antifungal, or anti-inflammatory properties. They are commonly used in clinical settings, dermatological treatments, and personal hygiene routines to address various skin concerns.
The main product types of medicated liquid soap include antibacterial, antifungal, antiviral, and other variants. Antibacterial medicated liquid soaps contain agents that target bacteria, helping to prevent infections and maintain personal hygiene. These soaps are made from a mix of natural and synthetic ingredients and are distributed through multiple channels, such as online stores, supermarkets, hypermarkets, specialty stores, pharmacies, and others. They are used in various applications, including household, healthcare, commercial, and industrial settings.
The medicated liquid soap market consists of sales of botanical-based medicated soap, moisturizing medicated soap, acne-control medicated soap, and deodorizing medicated soap. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The medicated liquid soap market size is expected to see rapid growth in the next few years. It will grow to $2.73 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing demand for preventive skin care, rising adoption of prescription-grade hygiene products, expansion of e-commerce pharmaceutical sales, growing focus on sensitive skin formulations, increasing regulatory oversight on topical products. Major trends in the forecast period include growing demand for antimicrobial personal care products, rising preference for dermatologically tested formulations, expansion of natural and herbal medicated soaps, enhanced focus on skin-specific therapeutic solutions, increasing use in clinical hygiene protocols.
The increasing prevalence of skin-related issues is expected to drive the growth of the medicated liquid soap market. Skin conditions such as acne, eczema, psoriasis, rashes, and infections are becoming more common due to rising exposure to environmental pollutants, which weaken the skin's barrier and trigger irritation. Medicated liquid soap helps address these concerns by eliminating harmful microbes that cause infections, acne, and irritation. It also contains active ingredients that cleanse thoroughly while calming inflammation and promoting skin repair. For example, in February 2025, Cancer Australia reported 18,257 new cases of skin melanoma in 2023, making up 11% of all new cancer cases, with 1,314 deaths from the disease. As skin issues become more widespread, the demand for products such as medicated liquid soap is increasing, fueling market growth.
Companies in the medicated liquid soap market are innovating with advanced products, such as antibacterial liquid soap, to enhance germ protection and offer a more effective and gentle cleansing experience. Antibacterial liquid soap is formulated to eliminate or inhibit bacterial growth on the skin, reducing the risk of infection and improving hygiene. For example, in April 2023, Dettol, a leading UK-based hygiene brand, introduced a reformulated version of its original liquid hand wash. The new formula provides 99.99% germ protection and a moisture seal benefit, while being dermatologically tested for gentle care. This enhanced version leaves hands feeling soft and nourished, offering both cleanliness and skin protection. Such innovations are helping to meet the growing demand for more effective, skin-friendly hygiene products.
In December 2023, Wipro Consumer Care and Lighting, an India-based personal care company, acquired three soap brands from VVF Limited. This acquisition strengthens Wipro’s position in the hygiene and wellness category by expanding its personal wash portfolio, which includes medicated liquid soaps. VVF Limited, a manufacturer of medicated liquid soap, has been a key player in this market. By acquiring these brands, Wipro aims to increase its market share in the fast-growing personal care segment, responding to the rising consumer demand for effective hygiene products.
Major companies operating in the medicated liquid soap market are Johnson & Johnson Services Inc., Unilever PLC, Reckitt Benckiser Group plc, Ecolab Inc., Kao Corporation, ITC Limited, Lion Corporation, Godrej Consumer Products Limited, GOJO Industries Inc., Vi-Jon LLC, Kutol Products Company Inc., Betco Corporation, Wipro Consumer Care and Lighting, Swisskem Healthcare, Trio Lifescience Pvt. Ltd., Kavit Soap Industries, Galderma, Glenmark Pharmaceuticals, Cipla, Beiersdorf AG, Sanofi, Perrigo Company plc.
North America was the largest region in the medicated liquid soap market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medicated liquid soap market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medicated liquid soap market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the medicated liquid soap market by increasing costs of imported active pharmaceutical ingredients, specialty surfactants, packaging materials, and formulation chemicals. Pharmaceutical and personal care manufacturers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces cost pressure on export-oriented soap production. These tariffs are raising manufacturing expenses and retail prices. However, they are also encouraging local ingredient sourcing, domestic formulation development, and investment in regional production facilities.
The medicated liquid soap market research report is one of a series of new reports that provides medicated liquid soap market statistics, including medicated liquid soap industry global market size, regional shares, competitors with a medicated liquid soap market share, detailed medicated liquid soap market segments, market trends and opportunities, and any further data you may need to thrive in the medicated liquid soap industry. This medicated liquid soap market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Medicated liquid soap is a specialized type of liquid soap that contains active pharmaceutical ingredients designed to treat or prevent specific skin conditions. Unlike regular cleansing soaps, medicated liquid soaps provide therapeutic benefits, often possessing antibacterial, antifungal, or anti-inflammatory properties. They are commonly used in clinical settings, dermatological treatments, and personal hygiene routines to address various skin concerns.
The main product types of medicated liquid soap include antibacterial, antifungal, antiviral, and other variants. Antibacterial medicated liquid soaps contain agents that target bacteria, helping to prevent infections and maintain personal hygiene. These soaps are made from a mix of natural and synthetic ingredients and are distributed through multiple channels, such as online stores, supermarkets, hypermarkets, specialty stores, pharmacies, and others. They are used in various applications, including household, healthcare, commercial, and industrial settings.
The medicated liquid soap market consists of sales of botanical-based medicated soap, moisturizing medicated soap, acne-control medicated soap, and deodorizing medicated soap. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Medicated Liquid Soap Market Characteristics
3. Medicated Liquid Soap Market Supply Chain Analysis
4. Global Medicated Liquid Soap Market Trends and Strategies
5. Medicated Liquid Soap Market Analysis of End Use Industries
7. Global Medicated Liquid Soap Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Medicated Liquid Soap Total Addressable Market (TAM) Analysis for the Market
9. Medicated Liquid Soap Market Segmentation
10. Medicated Liquid Soap Market Regional and Country Analysis
11. Asia-Pacific Medicated Liquid Soap Market
12. China Medicated Liquid Soap Market
13. India Medicated Liquid Soap Market
14. Japan Medicated Liquid Soap Market
15. Australia Medicated Liquid Soap Market
16. Indonesia Medicated Liquid Soap Market
17. South Korea Medicated Liquid Soap Market
18. Taiwan Medicated Liquid Soap Market
19. South East Asia Medicated Liquid Soap Market
20. Western Europe Medicated Liquid Soap Market
21. UK Medicated Liquid Soap Market
22. Germany Medicated Liquid Soap Market
23. France Medicated Liquid Soap Market
24. Italy Medicated Liquid Soap Market
25. Spain Medicated Liquid Soap Market
26. Eastern Europe Medicated Liquid Soap Market
27. Russia Medicated Liquid Soap Market
28. North America Medicated Liquid Soap Market
29. USA Medicated Liquid Soap Market
30. Canada Medicated Liquid Soap Market
31. South America Medicated Liquid Soap Market
32. Brazil Medicated Liquid Soap Market
33. Middle East Medicated Liquid Soap Market
34. Africa Medicated Liquid Soap Market
36. Medicated Liquid Soap Market Competitive Landscape and Company Profiles
37. Medicated Liquid Soap Market Other Major and Innovative Companies
40. Medicated Liquid Soap Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Medicated Liquid Soap Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses medicated liquid soap market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for medicated liquid soap? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medicated liquid soap market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Antibacterial; Antifungal; Antiviral; Other Product Types2) By Ingredient Type: Natural; Synthetic
3) By Distribution Channel: Online Stores; Supermarkets Or Hypermarkets; Specialty Stores; Pharmacies; Other Distribution Channels
4) By Application: Household; Healthcare; Commercial; Industrial
Subsegments:
1) By Antibacterial: Triclosan-Based Soaps; Chlorhexidine-Based Soaps; Benzalkonium Chloride Soaps; Herbal Antibacterial Soaps2) By Of Antifungal: Ketoconazole-Based Soaps; Clotrimazole-Based Soaps; Terbinafine-Based Soaps; Natural Antifungal Soaps
3) By Antiviral: Povidone-Iodine Soaps; Ethanol Or Isopropyl Alcohol-Based Soaps; Hydrogen Peroxide-Based Soaps; Essential Oil-Based Antiviral Soaps
4) By Other Product Types: Antiseptic Combination Soaps; Medicated Soaps For Dermatological Conditions; Sulfur-Based Soaps; Salicylic Acid-Based Soaps
Companies Mentioned: Johnson & Johnson Services Inc.; Unilever PLC; Reckitt Benckiser Group plc; Ecolab Inc.; Kao Corporation; ITC Limited; Lion Corporation; Godrej Consumer Products Limited; GOJO Industries Inc.; Vi-Jon LLC; Kutol Products Company Inc.; Betco Corporation; Wipro Consumer Care and Lighting; Swisskem Healthcare; Trio Lifescience Pvt. Ltd.; Kavit Soap Industries; Galderma; Glenmark Pharmaceuticals; Cipla; Beiersdorf AG; Sanofi; Perrigo Company plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Medicated Liquid Soap market report include:- Johnson & Johnson Services Inc.
- Unilever PLC
- Reckitt Benckiser Group plc
- Ecolab Inc.
- Kao Corporation
- ITC Limited
- Lion Corporation
- Godrej Consumer Products Limited
- GOJO Industries Inc.
- Vi-Jon LLC
- Kutol Products Company Inc.
- Betco Corporation
- Wipro Consumer Care and Lighting
- Swisskem Healthcare
- Trio Lifescience Pvt. Ltd.
- Kavit Soap Industries
- Galderma
- Glenmark Pharmaceuticals
- Cipla
- Beiersdorf AG
- Sanofi
- Perrigo Company plc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.78 Billion |
| Forecasted Market Value ( USD | $ 2.73 Billion |
| Compound Annual Growth Rate | 11.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
